About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: May 26, 2006
Weekly Roundup – 5-26-06
After a two-week hiatus, Weekly Roundup is back. Bad Legislative Action – An amendment to a House appropriations bill that would have provided for greater FDA authority over drug safety in post-marketing studies was stripped from the legislation. Expect hearings … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup – 5-26-06